NCI-supported cancer trials approaching "state of crisis", says IOM report
This article was originally published in Scrip
Executive Summary
A recent report by the US Institute of Medicine (IOM) has found that the system for conducting US-government supported cancer clinical trials is approaching a state of crisis, and it recommends that urgent changes be made to the US National Cancer Institute (NCI)-supported Clinical Trials Cooperative Group Program.